MULTI-CENTER, OPEN-LABEL, EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: THE TEMPO 4:4 TRIAL
ISN Academy, Vicente Torres, 177631
IMPACT OF TOLVAPTAN THERAPY ON DISEASE PROGRESSION IN NORMOTENSIVE AND HYPERTENSIVE (HBP) MEN AND WOMEN IN THE TEMPO 3:4 TRIAL
ISN Academy, Jaime Blais, 177632
SERUM ENDOCAN LEVELS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
ISN Academy, rumeyza kazancioglu, 177637
GENETIC VARIANTS rs737267, rs6449213, rs734553, rs733175 IN SLC2A9 GENE AND SERUM URIC ACID LEVELS IN ELDERLY ADULTS.
ISN Academy, Elizabeth Burciaga Favela, 177639
COMPARISON OF KIDNEY BIOPSIES AND BIOCHEMICAL CHARACTERISTICS FROM PATIENTS WITH CKDu IN SRI LANKA AND CENTRAL AMERICA
ISN Academy, Julia Wijkström, 177657
AN EVIDENCE-BASED CLINICAL CASE DEFINITION OF ACUTE MESOAMERICAN NEPHROPATHY
ISN Academy, Rebecca Fischer, 177661
VALIDATION OF A SIMPLE AND ECONOMIC HPLC-UV METHOD FOR THE SIMULTANEOUS DETERMINATION OF PLASMA LEVELS OF VANCOMYCIN, MEROPENEM, PIPERACILLIN AND TAZOBACTAM IN CRITICALLY ILL PATIENTS
ISN Academy, Lilia Rizo Topete, 177675
THE PREVALENCE AND FACTORS PREDICTIVE OF IRON DEFICIENCY IN ANEMIC PATIENTS WITH NON-DIALYZED CHRONIC KIDNEY DISEASE STAGES 3-5
ISN Academy, Gloria Ashuntantang, 177678
SAFETY PROFILE OF FERRIC CITRATE IN PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA FROM 2 RANDOMIZED CLINICAL TRIALS
ISN Academy, Katrin Uhlig, 177679
FERRIC CITRATE INCREASED HEMOGLOBIN IN TWO INDEPENDENT TRIALS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA
ISN Academy, JOHN NEYLAN, 177681
FERRIC CITRATE INCREASED HEMOGLOBIN FOR 24 WEEKS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT-CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY ANEMIA IN A PHASE 3 CLINICAL TRIAL OPEN-LABEL EXTENSION
ISN Academy, Pablo Pergola, 177682
MICROBIOLOGICAL PROFILE OF SPECIMENS SUBMITTED TO LABORATORIES IN A CHRONIC DIALYSIS POPULATION IN SOUTH AFRICA
ISN Academy, Naseema Sheik, 177684
INFECTIVE ENDOCARDITIS PRESENTING AS PAUCIIMMUNE VASCULITIS
ISN Academy, Mauro Braun, 177709
SPECTRUM OF IgG4 RELATED KIDNEY DISEASE AT A TERTIARY CARE CENTER IN NORTH INDIA
ISN Academy, NIDHI SINGH, 177710
TRIPLET PREGNANCY IN A DIABETIC MOTHER WITH KIDNEY TRANSPLANTATION, CASE REPORT AND REVIEW OF LITERATURE
ISN Academy, Tarek Mahmoud, 177711
POTASSIUM CHANNEL INHIBITOR IMPROVES ESTABLISHED DIABETIC NEPHROPATHY
ISN Academy, Carol Pollock, 177717
TOWARDS GENE THERAPY IN DIABETIC KIDNEY DISEASE – THE ROLE OF LONG NON-CODING RNA
ISN Academy, Carol Pollock, 177718
RELATIONSHIP OF SERUM RETINOL BINDING PROTEIN AND VASPIN TO METABOLIC SYNDROME IN CHRONIC KIDNEY DISEASE PATIENTS
ISN Academy, Sahier El Khashab, 177719
THE ROLE OF SERUM AMYLOID A IN DIABETES-INDUCED PERSISTENT INFLAMMATION IN PODOCYTES
ISN Academy, Brad Dieter, 177720
10-WEEK, BUT NOT 7-WEEK, DAPAGLIFLOZIN TREATMENT IMPROVES SEVERE RENAL IMPAIRMENT IN UNI-NEPHRECTOMIZED SDT FATTY RAT, A 10-WEEK MODEL OF ADVANCED RENAL COMPLICATIONS AND GFR DECLINE.
ISN Academy, Francois Briand, 177726
ASSOCIATION OF ALTERED TASTE PERCEPTION WITH MINERAL AND BONE DISORDER
ISN Academy, GABRIELA NUNEZ, 177733
DOUBLE MINI PERINONEAL EQUILIBRATION TEST (mini-PET) IN EVALUATION OF PERITONEAL MEMBRANE FUNCTION AND ITS DETERMINANTS
ISN Academy, Alexander Zemchenkov, 177761
2 YEARS EXPERIENCE ON CHRONIC AMBULATORY PERITONEAL DIALYSIS (CAPD) - A DESCRIPTIVE STUDY ON CAPD AS A NOVEL RENAL REPLACEMENT MODALITY IN SRI-LANKA
ISN Academy, Charaka Ratnayake, 177768
PREVALENCE OF RISK FACTORS FOR DEVELOPMENT OF PERITONITIS RELATED TO DIALYSIS IN PATIENTS WITH CKD IN PERITONEAL DIALYSIS PROGRAM AT A MEXICAN CENTER.
ISN Academy, Viridiana Morales, 177769
CHARACTERIZATION OF THE INTESTINAL MICROBIOTA IN PATIENTS FROM THE METROPOLITAN REGION OF CHILE IN HEMODIALYSIS AND PERITONEAL DIALYSIS THERAPY USING GUT LOW-DENSITY ARRAY (GULDA) qPCR.
ISN Academy, Francisca Pena, 177770
EFFECTS OF XANTHINE OXIDASE INHIBITORS (XOi) IN RATS SUBMITTED TO LPS
ISN Academy, Maria Fatima Ramos, 177783
EVALUATION OF THE EFFECT OF TWO MIXES OF PREBIOTIC FIBERS IN THE SIMULATOR OF THE HUMAN INTESTINAL MICROBIAL ECOSYSTEM (SHIME®)
ISN Academy, Natarajan Ranganathan, 177785
EFFICACY AND SAFETY OF ESAXERENONE (CS-3150) FOR TREATING EARLY DIABETIC NEPHROPATHY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II TRIAL
ISN Academy, Sadayoshi Ito, 177788
Association of Metabolic Syndrome and Renal Cell Carcinoma
ISN Academy, BENEDITO PEREIRA, 177789
EARLY RECURRENCE OF DIABETIC NEPHROPATHY IN KIDNEY ALLOGRAFTS: A NEW INSIGHT TO AN OLD DISEASE?
ISN Academy, Panupong Hansrivijit, 177790
Arterial hypertension after renal transplantation: prevalence and risk factors
ISN Academy, Telmoudi Aicha, 177814
Hemodialysis
ISN Academy, Alfred Cheung, 178818
SGLT2 Inhibitors: From Physiology to Application. Special Lecture
ISN Academy, Ernest Wright, 178872
Insulins
ISN Academy, Peter Rossing, 178871
Use of Diet in People with Advanced CKD
ISN Academy, Adamasco Cupisti, 178813
ESTABLISHING RENAL SERVICES IN FIJI: AN ISN SISTER RENAL CENTRE PROGRAM
ISN Academy, Angus Ritchie, 177818
CARDIOVASCULAR OUTCOMES REPORTED IN HEMODIALYSIS TRIALS; A SYSTEMATIC REVIEW
ISN Academy, David Johnson, 177821
IMPACT OF TRANSITIONS BETWEEN RENAL REPLACEMENT THERAPY MODALITIES: THE MONDO INITIATIVE
ISN Academy, Jessica Paola Bahena Lopez, 177823
IS AGE AN IMPORTANT FACTOR IN THE CHANGING INCIDENCE RATE OF RENAL REPLACEMENT THERAPY IN WESTERNIZED COUNTRIES?
ISN Academy, Vicky De Meyer, 177824
RESULTS OF A 35 YEARS TREATMENT PROGRAM OF ESRD IN A LOW-MIDDLE INCOME COUNTRY.
ISN Academy, Maria Gonzalez-Bedat, 177825
PAEDIATRIC DIALYIS IN A TERTIARY HEALTH CENTRE IN SOUTH WESTERN NIGERIA - AN UPDATE
ISN Academy, Adebowale Ademola, 177826
THIRTY SIX YEARS OF CHRONIC HEMODIALYSIS (CHD) IN CHILE. BETWEEN 1980-2016
ISN Academy, Poblete Hugo, 177827
DEPRESSIVE SYMPTOMS IN CHRONIC KIDNEY DISEASE: A COMPARATIVE STUDY AMONG PATIENTS IN HEMODIALYSIS AND CONSERVATIVE TREATMENT
ISN Academy, Geraldo da Silva Junior, 177846
COPING STRATEGIES AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY COMPARING PATIENTS RECEIVING CONSERVATIVE TREATMENT AND HEMODIALYSIS
ISN Academy, Geraldo da Silva Junior, 177847
CONSTRUCTION AND VALIDATION OF AN EDUCATIONAL TOOL FOR THE FOLLOW-UP AND PREVENTION OF COMPLICATIONS OF PATIENTS WITH CHRONIC KIDNEY DISEASE
ISN Academy, Geraldo da Silva Junior, 177848
LISTENING, LEARNING, LEADING: PARTNERING WITH PATIENTS TO TRANSFORM KIDNEY RESEARCH IN CANADA
ISN Academy, Helen Chiu, 177852
POPULATION-BASED EVIDENCE FOR CHRONIC KIDNEY DISEASE OF UNKNOWN AETIOLOGY (CKDu) IN INDIA
ISN Academy, Ben Caplin, 177854
EPIDEMIOLOGY OF CARDIOVASCULAR AND CHRONIC KIDNEY DISEASE RISK FACTORS SCREENING IN AN APPARENTLY HEALTHY POPULATION
ISN Academy, Di Benedetto Attilio, 177856
A GLOBAL PERSPECTIVE ON THE ASSOCIATION BETWEEN CHRONIC KIDNEY DISEASE, RENAL TRAITS AND TELOMERE LENGTH IN ADULTS-A SYSTEMATIC REVIEW
ISN Academy, Oluwatoyin Ameh, 177857
INCREASED PROTEINURIA IN PREGNANCY IS EXAGGERATED IN WOMEN WITH ALPORT SYNROME AND THIN BASEMENT MEMBRANE NEPHROPATHY
ISN Academy, Matt Hall, 177864
ARRHYTHMIAS AMONG PATIENTS WITH LEPTOSPIROSIS-ASSOCIATED ACUTE KIDNEY INJURY: A CASE SERIES IN NORTHEAST BRAZIL
ISN Academy, Geraldo da Silva Junior, 177887
THE FIRST YEAR’S EXPERIENCE OF A DEDICATED INPATIENT RENAL WARD IN MALAWI
ISN Academy, Alison Craik, 177888
NON-CRITICAL CARE HOSPITAL-ACQUIRED ACUTE KIDNEY INJURY: RISK FACTORS AND CLINICAL OUTCOMES
ISN Academy, Kateir Contreras, 177889
THE USE OF A MEDICAL APPLICATION IMPROVES THE IDENTIFICATION AND CLASSIFICATION OF ACUTE KIDNEY INJURY
ISN Academy, Rolando Claure-Del Granado, 177890
AETIOLOGY, PROGNOSTIC FACTORS AND TREATMENT OUTCOMES OF ACUTE KIDNEY INJURY IN CHILDREN IN A TERTIARY HOSPITAL IN SOUTH AFRICA
ISN Academy, Michelo Sharon Choopa, 177891
SALIVARY UREA NITROGEN DIPSTICK AS A SCREENING TOOL TO DETECT ACUTE KIDNEY DISEASE DUE TO MALARIA IN A LOW RESOURCE SETTING
ISN Academy, Viviane da Silva, 177894
Bilateral isolated renal mucormycosis in appaerently immunocompetent patients, review of literature and proposition of algorithm of diagnosis and management
ISN Academy, Dharmendra Bhadauria, 177899
CLINICAL AND EPIDEMIOLOGICAL PROFILE OF ACUTE KIDNEY INJURY FROM A TERTIARY CARE CENTRE IN SOUTH INDIA
ISN Academy, Hareesha Babu, 177902
IMPACT OF CORRECTION OF ANEMIA IN ESRD PATIENTS ON CEREBRAL CIRCULATION AND COGNITIVE FUNCTION
ISN Academy, Sahier El Khashab, 177933
PREGNANCY OUTCOMES IN END STAGE KIDNEY DISEASE PATIENTS AT CHO RAY HOSPITAL
ISN Academy, Thi Ngoc Thu Du, 177941
EARLY REFERRAL INCREASES PRE-EMPTIVE KIDNEY TRANSPLANT (PKT)
ISN Academy, Aklilu Yishak, 177948
POPULATION PHARMACOKINETICS AND PHARMACOGENETICS OF TACROLIMUS IN KIDNEY TRANSPLANT PATIENTS: OPTIMIZATION OF IMMUNOSUPPRESSIVE THERAPY
ISN Academy, Juan Reséndiz-Galván, 177950
Leptospirosis
ISN Academy, Antonio Seguro, 178796
Dengue Fever and AKI
ISN Academy, Emmanuel Burdmann, 178797
Snake Bite Induced AKI
ISN Academy, Santosh Varughese, 178798
Management of Non-Renal Diabetic Complications in People with Advanced CKD
ISN Academy, Merlin Thomas, 178814
Transplantation
ISN Academy, Jeremy Chapman, 178816
Peritoneal Dialysis
ISN Academy, Joanne Bargman, 178817
Transplante Renal
ISN Academy, Irene Noronha, 178819
Diálise Peritoneal
ISN Academy, Roberto Pecoits Filho, 178820
Hemodiálise
ISN Academy, Leda Lotaif, 178821
Claude Amiel Lecture - Therapeutic Progress in Amyloidosis
ISN Academy, Mark Pepys, 178837
Introducing ISN Research Portfolio: Objectives, Networks, Programs and Integration
ISN Academy, Marcello Tonelli, 178838
What Is ISN-ACT
ISN Academy, Vlado Perkovic, 178839
How to Design Better Trials
ISN Academy, Dick de Zeeuw, 178840
Challenges and Opportunities in CT in Nephrology Worldwide?
ISN Academy, Adeera Levin, 178841
iNET-CKD Overview
ISN Academy, Harold Feldman, 178842
Chronic Kidney Disease Progression among iNET‐CKD Cohorts
ISN Academy, Paula Orlandi, 178844
The Lillian Jean Kaplan International Prize Presentation by PKD Foundation. Award of the prizes to David Randolph Beier (USA) and Ronald Perrone (USA)
ISN Academy, Nathan Levin, 178848
Lillian Jean Kaplan International Prize Awardee Presentation: Analysis of Cystic Kidney Disease in Model Systems
ISN Academy, David Randolph Beier, 178849
Lessons Learned from DKD Trials
ISN Academy, Mark E. Cooper, 178859
Streamlining Clinical Trials to Enhance Feasibility
ISN Academy, David Wheeler, 178860
Conducting Clinical Trials in Low and Middle Income Countries
ISN Academy, Hong Zhang, 178862
Patient Priorities in Clinical Research
ISN Academy, Fiona Loud, 178863
Magnesium Homeostasis
ISN Academy, Pascal Houillier, 178864
Bartter-and Gitelman's Syndrome
ISN Academy, Markus Bleich, 178865
Acid-Base Regulation
ISN Academy, Carsten Wagner, 178866
Clean Water for AKI Prevention
ISN Academy, Dwomoa Adu, 178874
The Challenge of Water Purification for Dialysis
ISN Academy, Vivekanand Jha, 178875
Test Performance. How to Evaluate if a Test Is Useful (incl. STARD Statement)
ISN Academy, Germaine Wong, 178883
Lesson 1: The Transplant Kidney
ISN Academy, Mark Haas, 178884
Lesson 3: Drugs and the Kidney
ISN Academy, Leal Herlitz, 178885
Interactive Kidney Biopsy Cases
ISN Academy, Werner de León, 178888
Interactive Kidney Biopsy Cases
ISN Academy, Paisit Paueksakon, 178889
Genetic Adaptation to High Altitude. Special Lecture
ISN Academy, Abigail Bigham, 178890
Oxygen Tensions in The Kidney
ISN Academy, Masaomi Nangaku, 178891
Oxidative Stress of The Kidney
ISN Academy, Anupam Agarwal, 178892
Inflammation and Fibrosis Induced by Abnormal Oxygen Metabolism
ISN Academy, Zheng Dong, 178893
Mitochondrial dysfunction contributes to cyst proliferation via oxidative stress in autosomal dominant polycystic kidney disease.
ISN Academy, Reiko Inagi, 178894
CHRONIC EXPOSURE TO HYPOXIA ATTENUATES, RATHER THAN ENHANCE, RENAL INJURY AND INNATE IMMUNITY ACTIVATION IN THE REMNANT KIDNEY MODEL
ISN Academy, Lisienny Rempel, 178895

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings